lysine has been researched along with Myeloproliferative Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gill, H | 1 |
| Aranaz, P; Bryant, C; Carreno-Tarragona, G; Chase, A; Cross, NCP; Ernst, T; Lin, F; Score, J; Villasante, A; Waghorn, K; Yapp, S | 1 |
| Farina, A; Gurvich, N; Hurwitz, J; Menendez, S; Nimer, SD; Perna, F; Voza, F | 1 |
1 review(s) available for lysine and Myeloproliferative Disorders
| Article | Year |
|---|---|
Lysine-Specific Demethylase 1 (LSD1/KDM1A) Inhibition as a Target for Disease Modification in Myelofibrosis.
Topics: Hematopoietic Stem Cell Transplantation; Histone Demethylases; Humans; Lysine; Myeloproliferative Disorders; Primary Myelofibrosis | 2022 |
2 other study(ies) available for lysine and Myeloproliferative Disorders
| Article | Year |
|---|---|
Mutational mechanisms of EZH2 inactivation in myeloid neoplasms.
Topics: Animals; Cell Line; Enhancer of Zeste Homolog 2 Protein; Histones; Humans; Lysine; Mice; Mutation; Myeloproliferative Disorders | 2020 |
L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability.
Topics: Blotting, Western; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Chromosomal Proteins, Non-Histone; Chromosome Deletion; Chromosomes, Human, Pair 20; DNA Damage; DNA Replication; Genomic Instability; HEK293 Cells; Histones; Humans; Immunoprecipitation; K562 Cells; Lysine; Methylation; Myeloproliferative Disorders; Neoplasm Proteins; Protein Binding; Repressor Proteins; Retinoblastoma Protein; RNA Interference; Tumor Suppressor Proteins | 2010 |